We envision a future where mRNA technologies can unlock a faster and more adaptable path to new medicines. By uniting platform biology with delivery engineering and translational rigor, we aim to convert emerging insights and research into impactful, non-invasive, and effective therapies. Our goal is to build a scalable technology platform that reliably turns bold ideas into clinically meaningful treatments for currently undruggable targets.